Maia Biotechnology Inc (MAIA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MAIA Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Maia Biotechnology Inc balances growth, leverage, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent27.60
Cash & Short-term Investments27.00
Notes Receivable, Current0.05
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.64
Total Current Assets28.24
Other Assets, Noncurrent0.00
Research And Development Incentives Receivable-
Total Assets28.24
Liabilities
Accounts Payable, Current AC2.84
Accrued Liabilities, Current AC3.42
Other Liabilities, Current0.00
Total Current Liabilities6.26
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE1.31
WarrantLiabilityNoncurrent-
Total Liabilities7.57
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock144.65
Retained Earnings / Accumulated Deficit-123.94
Accumulated Other Comprehensive Income-0.04
Other Equity-0.04
Common Stockholder's Equity20.68
Total Stockholder's Equity20.68
Liabilities & Stockholder's Equity28.24
4 historic quarters locked

Sign in to unlock the full Maia Biotechnology Inc balance sheet history.

About Maia Biotechnology Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 10, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-036764

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.